All AbMole products are for research use only, cannot be used for human consumption.
For this product's availability, delivery time and price, please email inquiry@abmole.com directly or click the "Inquiry Now" button below.
Etalocib (LY293111), an orally active leukotriene B4 receptor antagonist, inhibits the binding of [3H]LTB4, with a Ki of 25 nM. Etalocib (LY293111) prevents LTB4-induced calcium mobilization with an lC50 of 20 nM. Etalocib (LY293111) induces apoptosis.
| Molecular Weight | 544.61 |
| Formula | C33H33FO6 |
| CAS Number | 161172-51-6 |
| Form | Solid |
| Solubility (25°C) | DMSO 100 mg/mL (ultrasonic) |
| Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
[3] Xian-Zhong Ding, et al. Anticancer Drugs. A novel anti-pancreatic cancer agent, LY293111
| Related Leukotriene Receptor Products |
|---|
| Pranlukast
Pranlukast is a selective cysteinyl leukotriene receptor antagonist. |
| Zafirlukast
Zafirlukast is a leukotriene receptor antagonist (LTRA) with IC50 of 0.6μM (IC50=7.0 µM for CYP2C9). |
| Cyclopentyl Chloroformate
Mandelic acid derivatives and their use as thrombin inhibitors. |
| LY255283
LY255283 is a competitive leukotriene B4 receptor antagonist, with an IC50 of about 100 nM. |
| CP-424174
CP-424174 is a cytokine release inhibitory compound (CRID) and also a reversible IL-1β inhibitor with an IC50 of 210 nM, which inhibits post-translational processing and secretion of IL-1β in human monocytes in the presence of LPS and ATP. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.
